Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |